Drug Eye Africa

Burkina Faso suspends Jus Cola Puissant drinks over undeclared sildenafil

The Faso Food and Drug Administration (Faso FDA) of Burkina Faso has suspended manufacturing and sale of beverages marketed as “Jus Cola Puissant” after detecting undeclared sildenafil.

Laboratory analysis of samples revealed the presence of sildenafil in products presented as soft drinks or food supplements. The active ingredient was not declared on labelling.

Consumers must stop buying and consuming these products immediately. Anyone still holding stock should cease use. The authority advised that anyone who has consumed the product and experiences chest pain, malaise, severe dizziness, sudden vision or hearing loss, or a painful erection lasting more than four hours should seek medical attention without delay and report the product consumed.

Wholesalers, shops, kiosks and online vendors must withdraw the products from stock and sales points immediately, place them in quarantine and comply with Faso FDA inspection team instructions for recovery. The manufacturing and sale of a beverage named “Le Roi” has been suspended as a precautionary measure.

Sildenafil requires medical supervision due to risks, particularly for people with cardiovascular disease or hypertension, elderly people, and those taking nitrate derivatives.

Source: Faso Food and Drug Administration (Faso FDA), “Alerte sanitaire : Présence de sildénafil dans les produits ‘Jus Cola Puissant’ – Suspension de la fabrication et de la vente”, 20 November 2026: https://fasofda.bf/fr/appGestion/listeCategoriePublic/701a5d61-d912-4a26-8c95-9a28c7a60fa8/

About the author

Drug Eye Africa Newsroom

Drug Eye Africa Newsroom

The Drug Eye Africa newsroom reports on medicines regulation, recalls and medicine quality across the African continent. Alerts are matched against the issuing authority's published notice before publication, and corrections are timestamped on the article rather than made silently.

Regulatory alerts and news, direct to your inbox

Independent pharmaceutical news and regulatory intelligence covering Africa.

Scroll to Top